Novi, MI, United States of America

Veerabahu Shanmugasundaram

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Veerabahu Shanmugasundaram. Retrieved from https://idiyas.com/inventor/veerabahu-shanmugasundaram

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Veerabahu Shanmugasundaram: Innovator in Estrogen Modulators

Introduction

Veerabahu Shanmugasundaram is a notable inventor based in Novi, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of estrogen modulators. His innovative work has led to the creation of a new class of isoxazoles, which are essential in the modulation of estrogen.

Latest Patents

Veerabahu holds 1 patent for his invention related to estrogen modulators. This patent focuses on the application of isoxazoles and their potential use in therapeutic settings. His research has opened new avenues for treatment options in hormone-related conditions.

Career Highlights

Veerabahu is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Simon Bailey and Stephen Douglas Barrett. Their collective expertise enhances the innovative environment at Pfizer, fostering advancements in pharmaceutical research.

Conclusion

Veerabahu Shanmugasundaram's work in the field of estrogen modulators exemplifies the impact of innovation in pharmaceuticals. His contributions are paving the way for future developments in hormone therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…